REKOVELLE follitropin delta (rhu) 36 microgram/1.08 mL solution for injection pre-filled multidose pen Austrália - inglês - Department of Health (Therapeutic Goods Administration)

rekovelle follitropin delta (rhu) 36 microgram/1.08 ml solution for injection pre-filled multidose pen

ferring pharmaceuticals pty ltd - follitropin delta, quantity: 36 microgram - injection, solution - excipient ingredients: phenol; methionine; sodium sulfate decahydrate; dibasic sodium phosphate dodecahydrate; polysorbate 20; phosphoric acid; sodium hydroxide; water for injections - controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (art) such as an in vitro fertilisation (ivf) or intracytoplasmic sperm injection (icsi) cycle.

REKOVELLE follitropin delta (rhu) 12 microgram/0.36 mL solution for injection pre-filled multidose pen Austrália - inglês - Department of Health (Therapeutic Goods Administration)

rekovelle follitropin delta (rhu) 12 microgram/0.36 ml solution for injection pre-filled multidose pen

ferring pharmaceuticals pty ltd - follitropin delta, quantity: 12 microgram - injection, solution - excipient ingredients: phenol; methionine; sodium sulfate decahydrate; dibasic sodium phosphate dodecahydrate; polysorbate 20; phosphoric acid; sodium hydroxide; water for injections - controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (art) such as an in vitro fertilisation (ivf) or intracytoplasmic sperm injection (icsi) cycle.

DURATOCIN carbetocin 100 microgram/mL injection vial Austrália - inglês - Department of Health (Therapeutic Goods Administration)

duratocin carbetocin 100 microgram/ml injection vial

ferring pharmaceuticals pty ltd - carbetocin, quantity: 100 microgram/ml - injection, solution - excipient ingredients: sodium hydroxide; water for injections; succinic acid; methionine; mannitol - duratocin is indicated for the prevention of uterine atony and excessive bleeding following delivery of the infant by caesarean section or vaginal delivery.,duratocin must be administered after delivery of the infant.

CORTIMENT budesonide 9 mg prolonged release tablet blister pack Austrália - inglês - Department of Health (Therapeutic Goods Administration)

cortiment budesonide 9 mg prolonged release tablet blister pack

ferring pharmaceuticals pty ltd - budesonide, quantity: 9 mg - tablet, modified release - excipient ingredients: stearic acid; lecithin; microcrystalline cellulose; hyprolose; lactose monohydrate; silicon dioxide; magnesium stearate; methacrylic acid copolymer; purified talc; titanium dioxide; triethyl citrate - cortiment prolonged-release tablets are indicated in adults for induction of remission in patients with mild to moderate active ulcerative colitis (uc) where 5-asa treatment is not sufficient or not tolerated.

DECAPEPTYL triptorelin acetate 100 micrograms/1 mL solution for injection in 1mL pre-filled syringe with integrated needle Austrália - inglês - Department of Health (Therapeutic Goods Administration)

decapeptyl triptorelin acetate 100 micrograms/1 ml solution for injection in 1ml pre-filled syringe with integrated needle

ferring pharmaceuticals pty ltd - triptorelin acetate, quantity: 100 microgram (equivalent: triptorelin, qty 95.6 microgram/ml) - injection, solution - excipient ingredients: glacial acetic acid; water for injections; sodium chloride - decapeptyl 100 micrograms/1 ml is indicated for down-regulation and prevention of premature luteinising hormone (lh) surges in women undergoing controlled ovarian hyperstimulation for assisted reproductive technologies (art).,in clinical trials decapeptyl 100 micrograms/1 ml has been used in cycles where urinary and recombinant human follicle stimulating hormone (fsh) as well as human menopausal gonadotrophin (hmg) were used for stimulation.

PENTASA mesalazine 4 g prolonged release granules sachet Austrália - inglês - Department of Health (Therapeutic Goods Administration)

pentasa mesalazine 4 g prolonged release granules sachet

ferring pharmaceuticals pty ltd - mesalazine, quantity: 4 g - granules, modified release - excipient ingredients: povidone; ethylcellulose - treatment of mild to moderate ulcerative colitis and crohn's disease and maintenance of remission.

PENTASA mesalazine 1 g prolonged release tablet blister pack Austrália - inglês - Department of Health (Therapeutic Goods Administration)

pentasa mesalazine 1 g prolonged release tablet blister pack

ferring pharmaceuticals pty ltd - mesalazine, quantity: 1 g - tablet, modified release - excipient ingredients: magnesium stearate; purified talc; ethylcellulose; povidone; microcrystalline cellulose - treatment of mild to moderate ulcerative colitis and crohn's disease and maintenance of remission.

PENTASA mesalazine 2 g prolonged release granules sachet Austrália - inglês - Department of Health (Therapeutic Goods Administration)

pentasa mesalazine 2 g prolonged release granules sachet

ferring pharmaceuticals pty ltd - mesalazine, quantity: 2 g - granules, modified release - excipient ingredients: povidone; ethylcellulose - treatment of mild to moderate ulcerative colitis and crohn's disease and maintenance of remission.

PENTASA mesalazine 1 g prolonged release granules sachet Austrália - inglês - Department of Health (Therapeutic Goods Administration)

pentasa mesalazine 1 g prolonged release granules sachet

ferring pharmaceuticals pty ltd - mesalazine, quantity: 1 g - granules, modified release - excipient ingredients: ethylcellulose; povidone - treatment of mild to moderate ulcerative colitis and crohn's disease and maintenance of remission.

ZOMACTON somatropin 10mg multidose powder for injection vial with diluent syringe Austrália - inglês - Department of Health (Therapeutic Goods Administration)

zomacton somatropin 10mg multidose powder for injection vial with diluent syringe

ferring pharmaceuticals pty ltd - somatropin -